{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:00:25Z","timestamp":1793714425073,"version":"4.6.1"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Ophthalmol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Recent studies of glaucoma, age-related macular degeneration, and diabetic retinopathy have demonstrated that flavoprotein fluorescence (FPF) can be utilized non-invasively as an indicator of mitochondrial oxidative stress in the retina. However, a comprehensive assessment of the validity and reliability of FPF in differentiating between healthy and diseased eyes across multiple disease states is lacking. Here, we evaluate the sensitivity and specificity of FPF in discriminating between healthy and diseased eyes in four leading causes of visual impairment worldwide, one of which has not been previously evaluated using FPF. We also evaluate the association between FPF and visual acuity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 88 eyes [21 eyes of 21 unaffected controls, 20 eyes from 20 retinal vein occlusion (RVO) patients, 20 eyes from 20 diabetic retinopathy (DR) patients, 17 eyes from 17 chronic exudative age-related macular degeneration (exudative AMD) patients, and 10 eyes from 10 central serous retinopathy (CSR) patients] were included in the present cross-sectional observational study. Eyes were imaged non-invasively using a specially configured fundus camera OcuMet Beacon\n                      <jats:sup>\u00ae<\/jats:sup>\n                      (OcuSciences, Ann Arbor, MI). The macula was illuminated using a narrow bandwidth blue light (455 \u2013 470 nm) and fluorescence was recorded using a narrow notch filter to match the peak emission of flavoproteins from 520 to 540 nm. AUROC analysis was used to determine the sensitivity of FPF in discriminating between diseased eyes and healthy eyes. Nonparametric Kruskal-Wallis Tests with\n                      <jats:italic>post-hoc<\/jats:italic>\n                      Mann Whitney U tests with the Holm-Bonferroni correction were performed to assess differences in FPF intensity, FPF heterogeneity, and best corrected visual acuity (BCVA) between the five groups. Spearman rank correlation coefficients were calculated to assess the relationship between FPF and BCVA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      AUROC analysis indicated that FPF intensity is highly sensitive for detecting disease, particularly for exudative AMD subjects (0.989; 95% CI = 0.963 \u2013 1.000,\n                      <jats:italic>p<\/jats:italic>\n                      =3.0 x 10\n                      <jats:sup>7<\/jats:sup>\n                      ). A significant difference was detected between the FPF intensity, FPF heterogeneity, and BCVA in all four disease states compared to unaffected controls (Kruskal-Wallis Tests,\n                      <jats:italic>p<\/jats:italic>\n                      = 1.06 x 10\n                      <jats:sup>-8<\/jats:sup>\n                      ,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.002,\n                      <jats:italic>p<\/jats:italic>\n                      = 5.54 x 10\n                      <jats:sup>-8<\/jats:sup>\n                      , respectively). Compared to healthy controls, FPF intensity values were significantly higher in RVO, DR, exudative AMD, and CSR (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001\n                      <jats:italic>, p<\/jats:italic>\n                      &amp;lt; 0.001\n                      <jats:italic>, p<\/jats:italic>\n                      &amp;lt; 0.001, and\n                      <jats:italic>p<\/jats:italic>\n                      = 0.001, respectively). Spearman rank correlation coefficient between FPF intensity and BCVA was \u03c1\n                      <jats:italic>= 0.595<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      = 9.62 x 10\n                      <jats:sup>-10<\/jats:sup>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite variations in structural retinal findings, FPF was found to be highly sensitive for detecting retinal disease. Significant FPF elevation were seen in all four disease states, with the exudative AMD patients exhibiting the highest FPF values compared to DR, CSR, and RVO subjects. This is consistent with the hypothesis that there is elevated oxidative stress in all of these conditions as previously demonstrated by blood studies. FPF intensity is moderately correlated with the late-in disease-marker BCVA, which suggests that the degree of FPF elevation can be used as a metabolic indicator of disease severity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fopht.2023.1110501","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T02:35:30Z","timestamp":1676514930000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Flavoprotein fluorescence elevation is a marker of mitochondrial oxidative stress in patients with retinal disease"],"prefix":"10.3389","volume":"3","author":[{"given":"Sofia","family":"Ahsanuddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernan A.","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Otero-Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Macanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mce.2012.12.024","article-title":"The spatial and temporal regulation of the hormonal signal. role of mitochondria in the formation of a protein complex required for the activation of cholesterol transport and steroids synthesis","volume":"371","author":"Poderoso","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.survophthal.2019.11.001","article-title":"Mitochondrial disorders and the eye","volume":"65","author":"Kisilevsky","year":"2020","journal-title":"Survey Ophthalmol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165686","article-title":"Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina","volume":"1866","author":"Nascimento-dos-Santos","year":"2020","journal-title":"BBA - Mol Basis Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41433-020-1110-y","article-title":"Functional imaging of mitochondria in retinal diseases using flavoprotein fluorescence","volume":"35","author":"Chen","year":"2021","journal-title":"Eye"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.06.010","article-title":"Mitochondria: Dynamic organelles in disease, aging, and development","volume":"125","author":"Chan","year":"2006","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-66014-7_10","article-title":"Mitochondria: The retina\u2019s achilles\u2019 heel in AMD","volume":"1256","author":"Ferrington","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.foodchem.2017.10.034","article-title":"Study on the effect of reactive oxygen species-mediated oxidative stress on the activation of mitochondrial apoptosis and the tenderness of yak meat","volume":"244","author":"Wang","year":"2018","journal-title":"Food Chem"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2005.05.012","article-title":"Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration","volume":"27","author":"Feher","year":"2006","journal-title":"Neurobiol Aging"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1038\/s41467-020-16902-5","article-title":"Endothelial activation of caspase-9 promotes neurovascular injury in retinal vein occlusion","volume":"11","author":"Avrutsky","year":"2020","journal-title":"Nat Commun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2337\/db10-0133","article-title":"Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy","volume":"60","author":"Zhong","year":"2011","journal-title":"Diabetes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9208489","article-title":"Retinal Diseases Associated with Oxidative Stress and the Effects of a Free Radical Scavenger (Edaravone)","volume":"2017","author":"Masuda","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2021.12.001.","article-title":"A 6-Gene Panel as a Signature to Predict Recovery from Advanced Heart Failure Using Transcriptomic Analysis","volume":"9","author":"Zou","year":"2022","journal-title":"Genes Diseases"},{"key":"B13","article-title":"In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics","volume":"36","author":"Delori","year":"1995","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B14","article-title":"Retinal flavoprotein autofluorescence as a measure of retinal health","volume":"106","author":"Elner","year":"2008","journal-title":"Trans Am Ophthalmological Soc"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2007.44","article-title":"Flavoprotein autofluorescence detection of early ocular dysfunction","volume":"126","author":"Elner","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1039\/C7IB00032D","article-title":"). blue light effect on retinal pigment epithelial cells by display devices","volume":"9","author":"Moon","year":"2017","journal-title":"Integr Biol Quantitative Biosci Nano to Macro"},{"key":"B17","first-page":"9","article-title":"Flavoprotein fluorescence is a marker of AMD progression","volume":"60","author":"Hsueh","year":"2019","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.126.7.934","article-title":"Rapid, noninvasive detection of diabetes-induced retinal metabolic stress","volume":"126","author":"Field","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181a3b923","article-title":"Detection of retinal metabolic stress resulting from central serous retinopathy","volume":"29","author":"Field","year":"2009","journal-title":"Retina"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3928\/15428877-20120712-02","article-title":"Noninvasive imaging of mitochondrial dysfunction in dry age-related macular degeneration","volume":"43","author":"Field","year":"2012","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3567306","article-title":"Flavoprotein fluorescence correlation with visual acuity response in patients receiving anti-VEGF injection for diabetic macular edema","volume":"2018","author":"Andrade Romo","year":"2018","journal-title":"Oxid Med Cell Longevity"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000000980","article-title":"Noninvasive detection of mitochondrial dysfunction in ocular hypertension and primary open-angle glaucoma","volume":"27","author":"Suwan","year":"2018","journal-title":"J Glaucoma"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogla.2021.12.006","article-title":"Mitochondrial dysfunction in primary open-angle glaucoma characterized by flavoprotein fluorescence at the optic nerve head","volume":"5","author":"Zhou","year":"2022","journal-title":"Ophthalmol Glaucoma"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13816810.2022.2144903","article-title":"Functional imaging of mitochondria in genetically confirmed retinal dystrophies using flavoprotein fluorescence","volume":"43","author":"Muste","year":"2022","journal-title":"Ophthalmic Genet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000002066","article-title":"Structural and metabolic imaging after short-term use of the balance goggles system in glaucoma patients: A pilot study","volume":"31","author":"Sun","year":"2022","journal-title":"J Glaucoma"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2007.00889.x","article-title":"Central serous chorioretinopathy","volume":"86","author":"Wang","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1985.01050120030015","article-title":"Photocoagulation for diabetic macular edema. early treatment diabetic retinopathy study report number 1. early treatment diabetic retinopathy study research group","volume":"103","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/IAE.0b013e318156777f","article-title":"Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study","volume":"28","author":"Chan","year":"2008","journal-title":"Retina"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.11.017","article-title":"Central serous chorioretinopathy: a personal perspective","volume":"149","author":"Yannuzzi","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S220845","article-title":"Central serous chorioretinopathy: Pathogenesis and management","volume":"13","author":"Semeraro","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.11.1570","article-title":"A simplified severity scale for age-related macular degeneration: AREDS report no. 18","volume":"123","author":"Ferris","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6435364","article-title":"Mitochondria as potential targets and initiators of the blue light hazard to the retina","volume":"2019","author":"Tao","year":"2019","journal-title":"Oxid Med Cell Longevity"},{"key":"B33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3892\/ijmm.13.1.87","article-title":"Neuro-optic cell apoptosis and microangiopathy in KKAY mouse retina","volume":"13","author":"Ning","year":"2004","journal-title":"Int J Mol Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-4835(03)00029-0","article-title":"Human RPE-monocyte co-culture induces chemokine gene expression through activation of MAPK and NIK cascade","volume":"76","author":"Bian","year":"2003","journal-title":"Exp Eye Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2011.06.023","article-title":"Retinal flavoprotein fluorescence correlates with mitochondrial stress, apoptosis, and chemokine expression","volume":"93","author":"Field","year":"2011","journal-title":"Exp Eye Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcp.10119","article-title":"Cellular response to oxidative stress: Signaling for suicide and survival","volume":"192","author":"Martindale","year":"2002","journal-title":"J Cell Physiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100858","article-title":"Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration","volume":"79","author":"Kaarniranta","year":"2020","journal-title":"Prog Retinal Eye Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2015.08.001","article-title":"The progress in understanding and treatment of diabetic retinopathy","volume":"51","author":"Stitt","year":"2016","journal-title":"Prog Retinal Eye Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.604205","article-title":"Phagocytosis by the retinal pigment epithelium: Recognition resolution, recycling","volume":"11","author":"Kwon","year":"2020","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.453","article-title":"Dysfunctional autophagy in RPE, a contributing factor in age-related macular degeneration","volume":"8","author":"Golestaneh","year":"2017","journal-title":"Cell Death Disease"},{"key":"B41","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1001\/archopht.122.4.598","article-title":"Current concepts in the pathogenesis of age-related macular degeneration","volume":"122","author":"Zarbin","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/112067219800800401","article-title":"Age-related macular degeneration: review of pathogenesis","volume":"8","author":"Zarbin","year":"1998","journal-title":"Eur J Ophthalmol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1998.0661","article-title":"Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells","volume":"68","author":"Ballinger","year":"1999","journal-title":"Exp Eye Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1076\/ceyr.22.3.165.5517","article-title":"Hydrogen peroxide stimulates apoptosis in cultured human retinal pigment epithelial cells","volume":"22","author":"Jin","year":"2001","journal-title":"Curr Eye Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0014-4835(03)00023-X","article-title":"Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration","volume":"76","author":"Liang","year":"2003","journal-title":"Exp Eye Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101201","article-title":"Mitochondrial oxidative stress in the retinal pigment epithelium (RPE) led to metabolic dysfunction in both the RPE and retinal photoreceptors","volume":"24","author":"Brown","year":"2019","journal-title":"Redox Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2174\/1389450054021990","article-title":"Molecular targets of diabetic cardiovascular complications","volume":"6","author":"Ahmad","year":"2005","journal-title":"Curr Drug Targets"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2010.12.006","article-title":"Oxidative stress, insulin signaling, and diabetes","volume":"50","author":"Rains","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12177-011-9068-4","article-title":"RPE barrier breakdown in diabetic retinopathy: seeing is believing","volume":"4","author":"Xu","year":"2011","journal-title":"J Ocul Biol Dis Infor"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2018.11.001","article-title":"Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies","volume":"138","author":"Bucolo","year":"2018","journal-title":"J Pharmacol Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.684680","article-title":"Attenuation of high glucose-induced damage in RPE cells through p38 MAPK signaling pathway inhibition","volume":"12","author":"Grazia","year":"2021","journal-title":"Front Pharmacol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i3.489","article-title":"Diabetic retinopathy - ocular complications of diabetes mellitus","volume":"6","author":"Nentwich","year":"2015","journal-title":"World J Diabetes"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/s22093490","article-title":"The role of different retinal imaging modalities in predicting progression of diabetic retinopathy: A survey","volume":"22","author":"Elsharkawy","year":"2022","journal-title":"Sensors"},{"key":"B55","article-title":"Macular diseases: Clinical manifestations","volume":"69","author":"Maumenee","year":"1965","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(96)30386-2","article-title":"Central serous chorioretinopathy in younger and older adults","volume":"103","author":"Spaide","year":"1996","journal-title":"Ophthalmology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2012.07.004","article-title":"Central serous chorioretinopathy: update on pathophysiology and treatment","volume":"58","author":"Nicholson","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"B58","article-title":"Levels of the oxidative stress biomarker malondialdehyde in tears of patients with central serous chorioretinopathy relate to disease activity","volume":"26","author":"Daruich","year":"2020","journal-title":"Mol Vision"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13892","article-title":"Elevation of serum oxidative stress in patients with retina vein occlusions","volume":"97","author":"Hsiang","year":"2019","journal-title":"Acta Ophthalmologica"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1080\/02713680701851902","article-title":"Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities","volume":"33","author":"Rehak","year":"2008","journal-title":"Curr Eye Res"}],"container-title":["Frontiers in Ophthalmology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2023.1110501\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T02:35:40Z","timestamp":1676514940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2023.1110501\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":60,"alternative-id":["10.3389\/fopht.2023.1110501"],"URL":"https:\/\/doi.org\/10.3389\/fopht.2023.1110501","relation":{},"ISSN":["2674-0826"],"issn-type":[{"value":"2674-0826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"article-number":"1110501"}}